DJIA 17,028.58 -2.56 -0.02%
NASDAQ 4,521.97 3.07 0.07%
S&P 500 1,987.42 3.29 0.17%
market minute promo

Antares Pharma, Inc. (NASDAQ: ATRS)



company name or ticker

Antares Pharma: Significant Value Or Value Trap?

Antares: An Analysis Of FDA Briefing Documents For September 17th Advisory Committee Meeting On Test

Antares: An Analysis Of FDA Briefing Documents For September 17th Advisory Committee Meeting On Testosterone Replacement Products

5 Breakout Stocks Under $10 Set to Soar

Antares Pharma's (ATRS) CEO Paul Wotton on Q2 2014 Results - Earnings Call Transcript

Antares: Uncertainty Creates An Exceptional Buying Opportunity

3 Stocks Crushed by the Market This Week

Find out which health-care stocks got beaten down the most by the market over the past few days.

Antares Pharma (ATRS) Crumbles: Stock Falls by 8.3% - Tale of the Tape

Why Antares Pharma Inc. Shares Dove

Antares shares go off track following the resignation of its CEO. Find out if this is something investors should be genuinely concerned about or if it's a short-term event.

Otrexup Sales Trajectory Points To First Profitable Quarter For Antares Pharma In 2015

Is Antares Pharma A Short-Squeeze Candidate?

See More Articles...